The Pharmacological Mechanisms of Xiaochaihutang in Treating Breast Cancer Based on Network Pharmacology

被引:6
|
作者
Zheng, Lin [1 ]
Jiang, Hongnan [2 ]
Li, Ruoqi [3 ]
Song, Liying [4 ]
Chen, Ruihan [5 ]
Dong, Honglin [1 ]
机构
[1] Second Hosp Shanxi Med Univ, Dept Vasc Surg, Taiyuan 030000, Peoples R China
[2] Second Hosp Shanxi Med Univ, Dept Breast Surg, Taiyuan 030000, Peoples R China
[3] Third Hosp Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Gen Surg Dept, Taiyuan 030032, Peoples R China
[4] Shanxi Med Univ, Taiyuan 030607, Shanxi, Peoples R China
[5] Shanxi Med Univ, Clin Med Coll 1, Taiyuan 030001, Peoples R China
关键词
ARREST; CELLS;
D O I
10.1155/2022/3900636
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background. As a classic prescription in Chinese medicine treatment, Xiaochaihutang (XCHT) can improve the clinical effect and reduce serum tumor markers in patients with breast cancer (BC). However, there has not been any study to confirm the mechanism. We used bioinformatics analysis and network pharmacology to find the potential targets. Methods. The differentially expressed genes (DEGs) of BC were identified from the Cancer Genome Atlas (TCGA) dataset. Then, we utilized weighted coexpression network analysis (WGCNA) with the same dataset. The target genes of BC were obtained by comparing genes of DEGs and in significant modules of WGCNA. Drug targets of XCHT from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database were intersected with the targets of BC. The protein-protein interaction (PPI) of the drug targets was analysed by using the STRING database. We utilized the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes analysis (KEGG) enrichment analysis to identify the specific pathways and key target proteins. Receiver operator characteristic (ROC) curve was used as the verification of drug targets. Molecular docking was performed to visualize the patterns of interactions between the effective molecule and targeted protein. Results. We obtained a set of 21 target genes, which mainly encode neurotransmitter receptors or related transporters, such as OPRD1, 5-HT2A, and so on. In addition, enrichment analyses of 21 target genes showed that they were mainly concentrated in pathways related to the nervous system. Molecular docking was performed on the target gene of BC. Six active compounds can enter the active pocket of target gene, namely, naringenin, beta-sitosterol, coumestrol, nuciferine, beta-sitosterol, and protopine, thereby exerting potential therapeutic effects in BC. Conclusions. Our analysis shows that the mechanism of XCHT in the treatment of BC is mainly acting on the neurogenesis in the microenvironment of breast tumor tissue.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Network pharmacology and molecular docking to reveal the pharmacological mechanisms of Abelmoschus esculentus (l.) moench in treating breast cancer
    Ifeanyi Edozie Otuokere
    Julian Ibeji Iheanyichukwu
    Onuchi Marygem Mac-kalunta
    Chinedum Ifeanyi Nwankwo
    Comfort Michael Ngwu
    Stella Mbanyeaku Ufearoh
    Brendan Chidozie Asogwa
    Henry Chibueze Osiagor
    Felix Chigozie Nwadire
    In Silico Pharmacology, 13 (1)
  • [2] Systematic elucidation of the pharmacological mechanisms of Rhynchophylline for treating epilepsy via network pharmacology
    Geng, Hua
    Chen, Xuqin
    Wang, Chengzhong
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2021, 21 (01)
  • [3] Systematic elucidation of the pharmacological mechanisms of Rhynchophylline for treating epilepsy via network pharmacology
    Hua Geng
    Xuqin Chen
    Chengzhong Wang
    BMC Complementary Medicine and Therapies, 21
  • [4] Potential mechanisms of Pyrrosiae Folium in treating prostate cancer based on network pharmacology and molecular docking
    Guo, Wen-Hua
    Zhang, Kun
    Yang, Lu-Hong
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2022, 48 (05) : 189 - 197
  • [5] Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology
    Chen, Lizhi
    Zhou, Yue
    Weng, Zheng
    Liu, Shuang
    Li, Ting
    Wang, Yanfang
    Yang, Yang
    Liu, Hongmei
    Huang, Wenhua
    AGING-US, 2023, 15 (20): : 11489 - 11507
  • [6] Network Pharmacology and Experimental Validation Explore the Pharmacological Mechanisms of Herb Pair for Treating Rheumatoid Arthritis
    Xu, Xi-Xi
    Shao, Hua
    Wang, Qiao-Xue
    Wang, Zi-Yuan
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (12) : 1808 - 1822
  • [7] Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer
    Li, Xiao-Mei
    Li, Mao-Ting
    Jiang, Ni
    Si, Ya-Chen
    Zhu, Meng-Mei
    Wu, Qiao-Yuan
    Shi, Dong-Chen
    Shi, Hui
    Luo, Qing
    Yu, Bing
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1189 - 1204
  • [8] Evaluation of the Mechanism of Yishan Formula in Treating Breast Cancer Based on Network Pharmacology and Experimental Verification
    Lin, Xiaoyue
    Chi, Wencheng
    Geng, Xue
    Jiang, Qinghui
    Ma, Baozhu
    Dai, Bowen
    Sui, Yutong
    Jiang, Jiakang
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (17) : 2583 - 2597
  • [9] Network Pharmacology and Molecular Docking Analysis on the Pharmacological Mechanisms of Modified Sanmiaosan in Treating Ulcerative Colitis
    Wang, Yong
    Sun, Ying
    Wang, Ruoran
    Du, Jisha
    Wang, Qingqing
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [10] Integrated Network Pharmacology and Metabolomics to Dissect the Mechanisms of Naringin for Treating Cervical Cancer
    Yin, Ziwei
    Hua, Xuefeng
    Lu, Minqiang
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (05) : 754 - 764